Hunter, A. M., Komrokji, R. S., Yun, S., Al Ali, N., Chan, O., Song, J., . . . Sallman, D. A. (2021). Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes. Blood Adv.
Citação norma ChicagoHunter, Anthony M., et al. "Baseline and Serial Molecular Profiling Predicts Outcomes With Hypomethylating Agents in Myelodysplastic Syndromes." Blood Adv 2021.
Citação norma MLAHunter, Anthony M., et al. "Baseline and Serial Molecular Profiling Predicts Outcomes With Hypomethylating Agents in Myelodysplastic Syndromes." Blood Adv 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.